Ambulatory blood pressure thresholds for diagnosis of hypertension in patients with and without type 2 diabetes based on cardiovascular outcomes

Chronobiology International

Volumn 30, Issue 1-2, 2013, Pages 132-144

  Hermida, Ramón C ^a   Ayala, Diana E ^a   Mojón, Artemio ^a   Fernández, José R ^a  

^a UNIVERSITY OF VIGO   (Spain)

Author keywords

Ambulatory blood pressure; Cardiovascular risk; Diagnostic thresholds; Type 2 diabetes

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ACTIMETRY; ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; CIRCADIAN RHYTHM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; RISK FACTOR; SLEEP; TIME;

ACTIGRAPHY; ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE MONITORING, AMBULATORY; CIRCADIAN RHYTHM; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SLEEP; TIME FACTORS;

EID: 84874145377     PISSN: 07420528     EISSN: 15256073     Source Type: Journal    
DOI: 10.3109/07420528.2012.702584     Document Type: Article

References (99)

1. Afsar B, Sezer S, Elsurer R, Ozdemir FN. (2007). Is HOMA index a predictor of nocturnal nondipping in hypertensives with newly diagnosed type 2 diabetes mellitus? Blood Press. Monit. 12:133-139. (Pubitemid 46743718)
2. Alli C, Avanzini F, Bettelli G, Colombo F, Corso R, Di Tullio M, Marchioli R, Mariotti G, Radice M, Taioli E, Terzian E, Tognoni G, Zussino A, and the participating doctors of the 'Gruppo di Studio Sulla Pressione Arteriosa nell'Anziano'. (1992). Prevalence and variability of orthostatic hypotension in the elderly. Results of the "Italian study on blood pressure in the elderly (SPAA)." Eur. Heart J. 13:178-182.
3. American Diabetes Association. (2007). Diagnosis and classification of diabetes mellitus. Diabetes Care 30(Suppl 1):S42-S47.
4. Ayala DE, Hermida RC,Mojón A, Fernández Jr. (2013a). Cardiovascular risk of resistant hypertension: Dependence on treatment-time regimen of blood pressure-lowering medications. Chronobiol. Int. 30:340-352.
5. Ayala DE, Moyá A, Crespo JJ, Castiñeira C, Domínguez-Sardiña M, Gomara S, Sineiro E, Mojón A, Fontao MJ, Hermida RC, on behalf of the Hygia Project Investigators. (2013b). Circadian pattern of ambulatory blood pressure in hypertensive patients with and without type 2 diabetes. Chronobiol. Int. 30:99-115.
6. Bangalore S, Kumar S, Lobach I, Messerli FH. (2011). Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: observations from traditional and Bayesian random-effects meta-analyses of randomized trials. Circulation 123:2799-2810.
7. Ben-Dov IZ, Kark JD, Ben-Ishay D, Mekler J, Ben-Arie L, Bursztyn M. (2007). Predictors of all-cause mortality in clinical ambulatory monitoring. Unique aspects of blood pressure during sleep. Hypertension 49:1235-1241. (Pubitemid 46809363)
8. Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Björklund- Bodegård K, Richart T, Ohkubo T, Kuznetsova T, Torp-Pedersen CH, Lind L, Ibsen H, Imai Y, Wang J, Sandoya E, O'Brien E, Staessen JA. (2007). Prognostic accuracy of day versus night ambulatory blood pressure: A cohort study. Lancet 370:1219-1229. (Pubitemid 47503300)
9. Bouhanick B, Bongard V, Amar J, Bousquel S, Chamontin B. (2008). Prognostic value of nocturnal blood pressure and reverse-dipping status on the occurrence of cardiovascular events in hypertensive diabetic patients. Diabetes Metab. 34:560-567.
10. Bur A, Herkner H, Vlcek M, Woisetschläger C, Derhaschnig U, Hirschl MM. (2002). Classification of blood pressure levels by ambulatory blood pressure in hypertension. Hypertension 40:817-822. (Pubitemid 35434900)
11. Cardoso CRL, Leite NC, Muxfeldt ES, Salles GF. (2012). Thresholds of ambulatory blood pressure associated with chronic complications in type 2 diabetes. Am. J. Hypertens. 25:82-88.
12. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, JonesDW,Materson BJ, Oparil S,Wright JT, Rocella EJ, the National High Blood Pressure Education Coordinating Committee. (2003). The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 289:2560-2571.
13. Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH, Gheeraert PJ, Missault LH, Braun JJ, Six RO, Van Der Niepen P, O'Brien E. (2003). Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N. Engl. J. Med. 348:2407-2415. (Pubitemid 36682819)
14. Crespo C, Aboy M, Fernández JR, Mojón A. (2012). Automatic identification of activity-rest periods based on actigraphy. Med. Biol. Eng. Comput. 50:329-340.
15. Crespo C, Fernández JR, Aboy M, Mojón A. (2013). Clinical application of a novel automatic algorithm for actigraphy-based activity and rest period identification to accurately determine awake and asleep ambulatory blood pressure parameters and cardiovascular risk. Chronobiol. Int. 30:43-54.
16. Cushman WC, Evans GW, Byington RP, Goff DC , Grimm RH Jr. , Cutler JA, Simons-Morton DG, Basile JN, Corson MA, Probstfield JL, Katz L, Peterson KA, FriedewaldWT, Buse JB, Bigger JT, GersteinHC, Ismail-Beigi F, ACCORD Study Group. (2010). Effects of intensive bloodpressure control in type 2 diabetes mellitus. N. Engl. J. Med. 362:1575-1585.
17. Cuspidi C, Meani S, Lonati L, Fusi V, Valerio C, Sala C, Magnaghi G, Maisaidi M, Zanchetti A. (2006). Short-term reproducibility of a non-dipping pattern in type 2 diabetic hypertensive patients. J. Hypertens. 24:647-653.
18. Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, Den Hond E, McCormack P, Staessen JA, O'Brien E. (2005). Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: The Dublin outcome study. Hypertension 46:156-161. (Pubitemid 40946507)
19. Eguchi K, Pickering TG, Hoshide S, Ishikawa J, Ishikawa S, Schwartz J, Shimada K, Kario K. (2008). Ambulatory blood pressure is a better marker than clinic blood pressure in predicting cardiovascular events in patients with/without type 2 diabetes. Am. J. Hypertens. 21:443-450. (Pubitemid 351450870)
20. Equiluz-Bruck S, Schnack C, Kopp HP, Schernthaner G. (1996). Nondipping of nocturnal blood pressure is related to urinary albumin excretion rate in patients with type 2 diabetes mellitus. Am. J. Hypertens. 9:1139-1143. (Pubitemid 126690028)
21. Fagard RH, Celis H, Thijs L, Staessen JA, Clement DL, De Buyzere ML, De Bacquer DA. (2008). Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension. Hypertension 51:55-61. (Pubitemid 350307104)
22. Fan HQ, Li Y, Thijs L, Hansen TW, Boggia J, KikuyaM, Björklund- Bodegard K, Richart T, Ohkubo T, Jeppesen J, Torp-Pedersen C, Dolan E, Kuznetsova T, Stolarz-Skrzypek K, Tikhonoff V, Malyutina S, Casiglia E, Nikitin Y, Lind L, Sandoya E, Kawecka-Jaszcz K, Imai Y, Ibsen H, O'Brien E, Wang J, Staessen JA. (2010). Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations. J. Hypertens. 28:2036-2045.
23. Fogari R, Zoppi A, Malamani GD, Lazzari P, Destro M, Corradi L. (1993). Ambulatory blood pressure monitoring in normotensive and hypertensive type 2 diabetes. Prevalence of impaired diurnal blood pressure patterns. Am. J. Hypertens. 6:1-7. (Pubitemid 23055797)
24. Hansen TW, Kikuya M, Thijs L, Li Y, Boggia J, Björklund- Bodegârd K, Torp-Pedersen C, Jeppesen J, Ibsen H, Staessen JA. (2008). Diagnostic thresholds for ambulatory blood pressure moving lower: A review based on a meta-analysis-clinical implications. J. Clin. Hypertens. (Greenwich). 10:377-381.
25. Head GA, Mihailidou AS, Duggan KA, Beilin LJ, Berry N, Brown MA, Bune AJ, Cowley D, Chalmers JP, Howe PR, Hodgson J, Ludbrook J, Mangoni AA, McGrath BP, Nelson MR, Sharman JE, Stowasser M, Ambulatory Blood Pressure Working Group of the High Blood Pressure Research Council of Australia. (2010). Definition of ambulatory blood pressure targets for diagnosis and treatment of hypertension in relation to clinic blood pressure: prospective cohort study. BMJ 340:c1104. doi: 10.1136/bmj.c1104.
26. Head GA, McGrath BP, Mihailidou AS, Nelson MR, SchlaichMP, Stowasser M, Mangoni AA, Cowley D, Brown MA, Ruta LA, Wilson A (2012). Ambulatory blood pressure monitoring in Australia: 20111 consensus position statement. J. Hypertens. 30:253-266.
27. Hermida RC. (1999). Time-qualified reference values for 24 h ambulatory blood pressure monitoring. Blood Press. Monit. 4:137-147.
28. Hermida RC. (2007). Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: rationale and design of the MAPEC study. Chronobiol. Int. 24:749-775. (Pubitemid 47263103)
29. Hermida RC, Ayala DE. (2003). Sampling requirements for ambulatory blood pressure monitoring in the diagnosis of hypertension in pregnancy. Hypertension 42:619-624. (Pubitemid 37237363)
30. Hermida RC, Fernández Jr. (1996). Computation of time-specified tolerance intervals for ambulatorily monitored blood pressure. Biomed. Instrum. Technol. 30:257-266. (Pubitemid 26161490)
31. Hermida RC, Smolensky MH. (2004). Chronotherapy of hypertension. Curr. Opin. Nephrol. Hypertens. 13:501-505. (Pubitemid 39150075)
32. Hermida RC, Mojón A, Fernández JR, Ayala DE. (1996). Computerbased medical system for the computation of blood pressure excess in the diagnosis of hypertension. Biomed. Instrum. Technol. 30:267-283. (Pubitemid 26161491)
33. Hermida RC, Fernández JR, Mojón A, Ayala DE. (2000). Reproducibility of the hyperbaric index as a measure of blood pressure excess. Hypertension 35:118-125. (Pubitemid 30054247)
34. Hermida RC, Ayala DE, Fernández JR, Mojón A, Alonso I, Calvo C. (2002a). Modeling the circadian variability of ambulatorily monitored blood pressure by multiple-component analysis. Chronobiol. Int. 19:461-481. (Pubitemid 34478039)
35. Hermida RC, Calvo C, Ayala DE, Fernández JR, Ruilope LM, López JE. (2002b). Evaluation of the extent and duration of the "ABPM effect" in hypertensive patients. J. Am. Coll. Cardiol. 40:710-717. (Pubitemid 34925618)
36. Hermida RC, Calvo C, Ayala DE, Mojón A, López JE. (2002c). Relationship between physical activity and blood pressure in dipper and nondipper hypertensive patients. J. Hypertens. 20:1097-1104. (Pubitemid 34913627)
37. Hermida RC, Mojón A, Fernández JR, Alonso I, Ayala DE. (2002d). The tolerance-hyperbaric test: A chronobiologic approach for improved diagnosis of hypertension. Chronobiol. Int. 19:1183-1211. (Pubitemid 36008225)
38. Hermida RC, Calvo C, Ayala DE, Domínguez MJ, Covelo M, Fernández JR, Fontao MJ, López JE. (2004). Administration-time- dependent effects of doxazosin GITS on ambulatory blood pressure of hypertensive subjects. Chronobiol. Int. 21:277-296. (Pubitemid 39014625)
39. Hermida RC, Ayala DE, Calvo C. (2005). Administration time-dependent effects of antihypertensive treatment on the circadian pattern of blood pressure. Curr. Opin. Nephrol. Hypertens. 14:453-459. (Pubitemid 41152708)
40. Hermida RC, Ayala DE, Calvo C, Portaluppi F, Smolensky MH. (2007). Chronotherapy of hypertension: administration-time dependent effects of treatment on the circadian pattern of blood pressure. Adv. Drug Deliv. Rev. 59:923-939. (Pubitemid 47531897)
41. Hermida RC, Ayala DE, Fernandez JR, Mojón A, Calvo C. (2007). Influence of measurement duration and frequency on ambulatory blood pressure monitoring. Rev. Esp. Cardiol. 60:131-138. (Pubitemid 46566967)
42. Hermida RC, Ayala DE, Portaluppi F. (2007c). Circadian variation of blood pressure: The basis for the chronotherapy of hypertension. Adv. Drug Deliv. Rev. 59:904-922. (Pubitemid 47534216)
43. Hermida RC, Ayala DE, Fernández JR, Calvo C. (2008). Chronotherapy improves blood pressure control and reverts the nondipper pattern in patients with resistant hypertension. Hypertension 51:69-76. (Pubitemid 350307106)
44. Hermida RC, Ayala DE, Mojón A, Fernández Jr. (2010). Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study. Chronobiol. Int. 27:1629-1651.
45. Hermida RC, Ayala DE, Fernández JR, Portaluppi F, Fabbian F, Smolensky MH. (2011a). Circadian rhythms in blood pressure regulation and optimization of hypertension treatment with ACE inhibitor and ARB medications. Am. J. Hypertens. 24:383-391.
46. Hermida RC, Ayala DE, Mojón A, Fernández Jr. (2011b). Influence of time of day of blood pressure-lowering treatment on cardiovascular risk in hypertensive patients with type 2 diabetes. Diabetes Care 34:1270-1276.
47. Hermida RC, Ayala DE, Mojón A, Fernández Jr. (2011c). Decreasing sleep-time blood pressure determined by ambulatory monitoring reduces cardiovascular risk. J. Am. Coll. Cardiol. 58:1165-1173.
48. Hermida RC, Ayala DE, Mojón A, Fernández Jr. (2011d). Bedtime dosing of antihypertensive medications reduces cardiovascular risk in CKD. J. Am. Soc. Nephrol. 22:2313-2321.
49. Hermida RC, Ayala DE, Mojón A, Fernández Jr. (2012a). Sleep-time blood pressure and the prognostic value of isolated-office and masked hypertension. Am. J. Hypertens. 25:297-305.
50. Hermida RC, Ayala DE, Mojón A, Fernández Jr. (2012b). Sleep-time blood pressure as a therapeutic target for cardiovascular risk reduction in type 2 diabetes. Am. J. Hypertens. 25:325-334.
51. Hermida RC, Ayala DE, Fernández JR, Mojón A. (2013a). Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction. Chronobiol. Int. 30:68-86.
52. Hermida RC, Ayala DE, Fernández JR, Mojón A, Smolensky MH, Fabbian F, Portaluppi F. (2013b). Administration-time differences in effects of hypertension medications on ambulatory blood pressure regulation. Chronobiol. Int. 30:280-314.
53. Hermida RC, Ayala DE, Fontao MJ, Mojón A, Fernández Jr. (2013). Ambulatory blood pressure monitoring: importance of sampling rate and duration - 48 versus 24 hours - on the accurate assessment of cardiovascular risk. Chronobiol. Int. 30:55-67.
54. Hermida RC, Ayala DE, Mojón A, Fernández Jr. (2013d). Cardiovascular risk of essential hypertension: influence of class, number, and treatment-time regimen of hypertension medications. Chronobiol. Int. 30:315-327.
55. Hermida RC, Ayala DE, Mojón A, Fernández Jr. (2013e). Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level - the "normotensive nondipper" paradox. Chronobiol. Int. 30:87-98.
56. Hermida RC, Ayala DE, Mojón A, Fernández Jr. (2013f). Role of timeof-day of hypertension treatment on the J-shaped relationship between blood pressure and cardiovascular risk. Chronobiol. Int. 30:328-339.
57. Irie K, Yamaguchi T, Minematsu K, Omae T. (1993). The J-curve phenomenon in stroke recurrence. Stroke 24:1844-1849. (Pubitemid 23352714)
58. Kendall DM. (2011). Blood pressure targets in diabetes: is this the time for change. J. Clin. Hypertens. (Greenwich) 13:258-262.
59. Kikuya M, Ohkubo T, Asayama K, Metoki H, Obara T, Saito S, Hashimoto J, Totsune K, Hoshi H, Satoh H, Imai Y. (2005). Ambulatory blood pressure and 10-year risk of cardiovascular and noncardiovascular mortality. The Ohasama Study. Hypertension 45:240-245. (Pubitemid 40179967)
60. Kikuya M, Hansen TW, Thijs L, Björklund-Bodegård K, Kuznetsova T, Ohkubo T, Richart T, Torp-Pedersen C, Lind L, Ibsen H, Imai Y, Staessen JA, International Database on Ambulatory blood pressure monitoring in relation to Cardiovascular Outcomes Investigators. (2007). Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk. Circulation 115:2145-2152. (Pubitemid 46659066)
61. Levey AS, Stevens LA, Schmid CH, Zhang Y, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, for the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI). (2009). A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150:604-612.
62. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Struijker HAJ, Zanchetti A. (2007). 2007 guidelines for the management of arterial hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens. 25:1105-1187.
63. Manfredini R, Gallerani M, Portaluppi F, Fersini C. (1996). Relationships of the circadian rhythms of thrombotic, ischemic, hemorrhagic, and arrhythmic events to blood pressure rhythms. Ann. N. Y. Acad. Sci. 783:141-158. (Pubitemid 26372087)
64. Manfredini R, Portaluppi F, Zamboni P, Salmi R, Gallerani M. (1999). Circadian variation in spontaneous rupture of abdominal aorta. Lancet 353:643-644. (Pubitemid 29087990)
65. Manfredini R, Boari B, Bressan S, Gallerani M, Salmi R, Portaluppi F, Mehta RH. (2004). Influence of circadian rhythm on mortality after myocardial infarction: Data from a prospective cohort of emergency calls. Am. J. Emerg. Med. 22:555-559. (Pubitemid 40143236)
66. Messerli FH, Williams B, Ritz E. (2007). Essential hypertension. Lancet 370:591-603. (Pubitemid 47247855)
67. Minutolo R, Agarwal R, Borrelli S, Chiodini P, Bellizzi V, Nappi F, Cianciaruso B, Zamboni P, Conte G, Gabbai FB, De Nicola L. (2011). Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease. Arch. Intern. Med. 171:1090-1098.
68. National Institute for Health and Clinical Excellence. (2011). Hypertension: The clinical management of primary hypertension in adults. Clinical guideline: Methods, evidence and recommendations. accessed May 28, 2012, from http://guidance.nice.org. uk/CG/Wave2/14.
69. National Kidney Foundation. (2002). K/DOQI clinical practice guidelines on chronic kidney disease: Evaluation, classification and stratification. Am. J. Kidney Dis. 39(2 Suppl 1):S1-S266.
70. Ohkubo T, Imai Y, Tsuji I, Nagai K, Ito S, Satoh H, Hisamichi S. (1998). Reference values for 24-hour ambulatory blood pressure monitoring based on a prognostic criterion: The Ohasama Study. Hypertension 32:255-259. (Pubitemid 28376481)
71. Okumura K, Ohya Y, Maehara A, Wakugami K, Iseki K, Takishita S. (2005). Effects of blood pressure levels on case fatality after acute stroke. J. Hypertens. 23:1217-1223. (Pubitemid 40862726)
72. Palmas W, Pickering T, Teresi J, Schwartz JE, Eguchi K, Field L, Weinstock RS, Shea S (2008). Nocturnal blood pressure elevation predicts progression of albuminuria in elderly people with type 22 diabetes. J. Clin. Hypertens. (Greenwich) 10:12-20.
73. Perloff D, Sokolow M, Cowan R. (1983). The prognostic value of ambulatory blood pressures. JAMA 249:2792-2798. (Pubitemid 13093711)
74. Pinotti M, Bertolucci C, Portaluppi F, Colognesi I, Frigato E, Foa A, Bernardi F. (2005). Daily and circadian rhythms of tissue factor pathway inhibitor and factor VII activity. Arterioscler. Thromb. Vasc. Biol. 25:646-649. (Pubitemid 40315692)
75. Pistrosch F, Reissmann E, Wildbrett J, Koehler C, Hanefeld M. (2007). Relationship between diurnal blood pressure variation and diurnal blood glucose levels in type 2 diabetic patients. Am. J. Hypertens. 20:541-545. (Pubitemid 46678702)
76. Portaluppi F, Hermida RC. (2007). Circadian rhythms in cardiac arrhythmias and opportunities for their chronotherapy. Adv. Drug Deliv. Rev. 59:940-951. (Pubitemid 47534217)
77. Portaluppi F, Smolensky MH. (2007). Circadian rhythmic and environmental determinants of 24-hour blood pressure regulation in normal and hypertensive conditions. In White WB (Ed.). Blood pressure monitoring in cardiovascular medicine and therapeutics. Totowa, NJ: Humana Press, 135-1588
78. Portaluppi F, Smolensky MH. (2010). Perspectives on the chronotherapy of hypertension based on the results of the MAPEC study. Chronobiol. Int. 27:1652-1667.
79. Portaluppi F, Montanari L, Ferlini M, Gilli P. (1990). Altered circadian rhythms of blood pressure and heart rate in non-hemodialysis chronic renal failure. Chronobiol. Int. 7:321-327.
80. Portaluppi F, Trasforini G, Margutti A, Vergnani L, Ambrosio MR, Rossi R, Bagni B, Pansini R, degli Uberti EC. (1992). Circadian rhythm of calcitonin gene-related peptide in uncomplicated essential hypertension. J. Hypertens. 10:1227-1234.
81. Portaluppi F, Cortelli P, Avoni P, Vergnani L, Contin E, Maltoni P, Pavani A, Sforza E, degli Uberti EC, Gambetti P, Lugaresi E. (1994). Diurnal blood pressure variation and hormonal correlates in fatal familial insomnia. Hypertension 23:569-576. (Pubitemid 24129349)
82. Portaluppi F, Vergnani L, Manfredini R, Fersini C. (1996). Endocrine mechanisms of blood pressure rhythms. Ann. N. Y. Acad. Sci. 783:113-131. (Pubitemid 26372085)
83. Portaluppi F, Pansini F, Manfredini R, Mollica G. (1997). Relative influence of menopausal status, age, and body mass index on blood pressure. Hypertension 29:976-979. (Pubitemid 27152468)
84. Portaluppi F, Boari B, Manfredini R. (2004). Oxidative stress in essential hypertension. Curr. Pharm. Des. 10:1695-1698. (Pubitemid 38559779)
85. Portaluppi F, Smolensky MH, Touitou Y. (2010). Ethics and methods for biological rhythm research on animals and human beings. Chronobiol. Int. 27:1911-1929.
86. Portaluppi F, Tiseo R, Smolensky MH, Hermida RC, Ayala DE, Fabbian F. (2012). Circadian rhythms and cardiovascular health. Sleep Med. Rev. 16:151-166.
87. Rutter MK, McComb JM, Forster J, Brady S, Marshall SM. (2000). Increased left ventricular mass index and nocturnal systolic blood pressure in patients with Type 2 diabetes mellitus and microalbuminuria. Diabet. Med. 17:321-325. (Pubitemid 30266128)
88. Salles GF, Cardoso CR, Muxfeldt ES. (2008). Prognostic influence of office and ambulatory blood pressures in resistant hypertension. Arch. Intern. Med. 168:2340-2346.
89. Sehestedt T, Hansen TW, Li Y, Richart T, Boggia J, Kikuya M, Thijs L, Stolarz-Skrzypek K, Casiglia E, Tikhonoff V, Malyutina S, Nikitin Y, Björklund-Bodegård K, Kuznetsova T, Ohkubo T, Lind L, Torp-Pedersen C, Jeppesen J, Ibsen H, Imai Y, Wang J, Sandoya E, Kawecka-Jaszcz K, Staessen JA. (2011). Are blood pressure and diabetes additive or synergistic risk factors? Outcome in 8494 subjects randomly recruited from 10 populations. Hypertens. Res. 34:714-721.
90. Smolensky MH, Portaluppi F. (1999). Chronopharmacology and chronotherapy of cardiovascular medications: relevance to prevention and treatment of coronary heart disease. Am. Heart J. 137(4 Pt 2):S14-S24. (Pubitemid 29162888)
91. Smolensky MH, Hermida RC, Castriotta RJ, Portaluppi F. (2007). Role of sleep-wake cycle on blood pressure circadian rhythms and hypertension. Sleep Med. 8:668-680. (Pubitemid 47192885)
92. Smolensky MH, Hermida RC, Ayala DE, Tiseo R, Portaluppi F. (2010). Administration-time-dependent effect of blood pressure-lowering medications: basis for the chronotherapy of hypertension. Blood Press. Monit. 15:173-180.
93. Smolensky MH, Siegel RA, Haus E, Hermida R, Portaluppi F. (2012). Biological rhythms, drug delivery, and chronotherapeutics. In Siepmann J, Siegel RA, Rathbone MJ (Eds.). Fundamentals and applications of controlled release drug delivery. Heidelberg, Germany: Springer Verlag, 359-443.
94. Trasforini G, Margutti A, Portaluppi F, Menegatti M, Ambrosio MR, Bagni B, Pansini R, Degli Uberti EC. (1991). Circadian profile of plasma calcitonin gene-related peptide in healthy man. J. Clin. Endocrinol. Metab. 73:945-951. (Pubitemid 21901129)
95. Varani K, Gessi S, Caiazza A, Rastelli G, Portaluppi F, Borea PA. (1999). Platelet alpha2-adrenoceptor alterations in patients with essential hypertension. Br. J. Clin. Pharmacol. 47:167-172. (Pubitemid 29078015)
96. Varani K, Portaluppi F, Merighi S, Ongini E, Belardinelli L, Borea PA. (1999b). Caffeine alters A2A adenosine receptors and their function in human platelets. Circulation 99:2499-2502. (Pubitemid 29228278)
97. Varani K, Portaluppi F, Gessi S, Merighi S, Ongini E, Belardinelli L, Borea PA. (2000). Dose and time effects of caffeine intake on human platelet adenosine A(2A) receptors: functional and biochemical aspects. Circulation 102:285-289. (Pubitemid 30457577)
98. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistell M, Guerrieri M, Gatteschi C, Zampi I, Santucci A, Santucci C, Reboldi G. (1994). Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension 24:793-801. (Pubitemid 24363980)
99. Voko Z, Bots ML, Hofman A, Koudstaal PJ, Witteman JCM, Breteler MMB. (1999). J-shaped relation between blood pressure and stroke in treated hypertensives. Hypertension 34:1181-1185. (Pubitemid 30002379)